Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Brooks Hill Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Brooks Hill Partners

Brooks Hill Partners

Operating

Brooks Hill Partners: A strategy consulting and seed-stage investment firm, specializing in healthcare and technology sectors.

Location
Waltham, MA, US
Founded
2016
Firm
Compare
Portfolio
Employees
Website

Brooks Hill Partners is a strategy consulting and seed-stage investment firm specializing in the healthcare and technology sectors. The firm focuses on early-stage investments, partnering with passionate and driven companies and entrepreneurs. Brooks Hill Partners provides strategic and analytical resources to help management teams organically create value and foster growth within the life sciences and health tech industries.

Notable portfolio companies include Astrocyte Pharmaceuticals, Cake, and Deep 6 AI. The firm is led by key partners who bring extensive experience from both mega-cap corporations and innovative start-ups. Brooks Hill Partners prides itself on bridging the gap between large company expertise and the agility of smaller enterprises, offering unique value-add services that enhance the growth trajectory of their portfolio companies.

Brooks Hill Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments5
Current Portfolio Count5
Total Portfolio Exits0

Top Investment Stages

Seed4 (80.0%)
Pre-Seed1 (20.0%)

Stage Mix

Seed 80%Pre-Seed 20%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Professional Credentials Exchange logo

Professional Credentials Exchange

CAKE logo

CAKE

Deep 6 AI logo

Deep 6 AI

Astrocyte Pharmaceuticals logo

Astrocyte Pharmaceuticals

Wasabi Technologies logo

Wasabi Technologies

Brooks Hill Partners - Similar Investment Firms

Brook Venture Partners logo

Brook Venture Partners

brookventure.com

Brothers Brook logo

Brothers Brook

brothersbrook.com

Hillcrest Venture Partners logo

Hillcrest Venture Partners

Snow Hill Partners logo

Snow Hill Partners

snowhill.vc

Brookline Venture Partners logo

Brookline Venture Partners

Pine Brook Partners logo

Pine Brook Partners

Hilltop Venture Partners logo

Hilltop Venture Partners

Brookline Capital Markets logo

Brookline Capital Markets

Great Hill Partners logo

Great Hill Partners

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

City Hill Ventures logo

City Hill Ventures

Sternhill Associates logo

Sternhill Associates

Brookline Partners logo

Brookline Partners

Kline Hill Partners logo

Kline Hill Partners

klinehill.com

Brooks Hill Partners - Classification

NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions